Prostamax Peptide Description
Prostamax is a synthetic Khavinson bioregulator peptide with profound effects on DNA condensation in a number of cells. The peptide was developed by Vladimir Khavinson, a leading scientist who has authored 196 patents and 775 scientific publications in the field of peptide bioregulation and anti-aging research.
Researchers investigating DNA condensation, gene expression modulation, and cellular aging mechanisms will find Prostamax essential for examining how short peptides influence chromatin structure in lymphocytes and prostate cell cultures.
Peptide Specifications
- Sequence: Lys-Glu-Asp-Pro (KEDP)
- Molecular Formula: C₂₀H₃₃N₅O₉
- Molecular Weight: 487.5 g/mol
- PubChem CID: 9848296
- Synonyms: SCHEMBL6660498
- IUPAC Name: (2S)-1-[(2S)-3-carboxy-2-[[(2S)-4-carboxy-2-[[(2S)-2,6-diaminohexanoyl]amino]butanoyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
- Storage: This lyophilized preparation is stable at room temperature when guarded from light, but should be kept at -20°C for long term storage, preferably with desiccant
Research Applications
- Chromatin Studies
- Cellular Aging
- Prostate Research
- Epigenetic Regulation
- Chronic Inflammation Pathways
- Short Description:
- Prostamax is a synthetic tetrapeptide (Lys-Glu-Asp-Pro) belonging to the Khavinson peptide family, developed as a bioregulator peptide for in vitro studies on prostate health and anti-aging mechanisms.
- Container:
- Glass Vial
- Presentation:
- Liquid
